The Uromigos at ASCO GU 2023: Discussing PARPi for CRPC With Michael Morris, MD

By The Uromigos - Last Updated: August 1, 2023

The Uromigos met with Michael Morris, MD while at the 2023 ASCO GU Cancers Symposium to discuss PARP inhibition for castration-resistant prostate cancer and the differing opinions on how and when it should be utilized.
Dr. Morris is a prostate cancer specialist and researcher, and the Prostate Cancer Section Head at Memorial Sloan Kettering Cancer Center.

Post Tags:Uromigos-ASCO GUUromigos-Prostate Cancer